LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway
Oncology Reports · 2023
DOI: 10.3892/or.2023.8497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2023. Verfasst von Sijia Han und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, P.R. China. Hauptthemen laut MEDLINE: Wnt Signaling Pathway, Breast Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110022, P.R. China.
Zitieren
APA
Han, S., Jin, X., Hu, T., & Chi, F. (2023). LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway. Oncology Reports. https://doi.org/10.3892/or.2023.8497
Vancouver
Han S, Jin X, Hu T, Chi F. LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway. Oncology Reports. 2023. doi:10.3892/or.2023.8497
BibTeX
@article{Han2023,
author = {Han, Sijia and Jin, Xueying and Hu, Tianyu and Chi, Feng},
title = {LAPTM5 regulated by FOXP3 promotes the malignant phenotypes of breast cancer through activating the Wnt/β‑catenin pathway},
journal = {Oncology Reports},
year = {2023},
doi = {10.3892/or.2023.8497}
}
EUVIMED